FDA calls Pfizer Estring marketing misleading

The Food and Drug Administration's Office of Prescription Drug Promotion sent a warning letter to Pfizer, following its review of a direct-to-consumer video discussing the Estring (estradiol) vaginal ring on the michiganmomliving.com website. The video is of a doctor and her patient, both of whom are Pfizer spokespeople, discussing the benefits of the product.